Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow HUM
Humana Inc. (HUM) EBITDA
Humana Inc.'s EBITDA for fiscal 2025 was $3.5B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $3.5B. Over the past ten years it has ranged from $2.2B (fiscal 2016) to $5.6B (fiscal 2020); the current reading is higher than 27% of that period. Humana Inc. ranks 5th of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $3.5B | (0.06%) |
| FY2024 | $3.5B | (28.40%) |
| FY2023 | $4.9B | 6.14% |
| FY2022 | $4.6B | 20.31% |
| FY2021 | $3.9B | (31.08%) |
| FY2020 | $5.6B | 48.71% |
| FY2019 | $3.8B | 3.66% |
| FY2018 | $3.6B | (23.45%) |
| FY2017 | $4.7B | 115.19% |
| FY2016 | $2.2B | (21.05%) |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $1.5B | (20.53%) |
| Mar 2026 | $1.9B | — |
| Dec 2025 | −$614.0M | — |
| Sep 2025 | $604.0M | (53.86%) |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $26.0B |
| CVS CVS Health Corporation compare | $18.5B |
| CI Cigna Group compare | $12.7B |
| ELV Elevance Health, Inc. compare | $8.8B |
| HUM Humana Inc. | $3.5B |
| OSCR Oscar Health, Inc. compare | $632.0M |
| MOH Molina Healthcare, Inc compare | $371.0M |
| CLOV Clover Health Investments, Corp. compare | −$18.2M |
| CNC Centene Corporation compare | −$4.4B |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on HUM
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement